NewGenIvf Group (NASDAQ:NIVF) Shares Scheduled to Reverse Split on Tuesday, September 1st

NewGenIvf Group Limited (NASDAQ:NIVF)’s stock is set to reverse split on Tuesday, September 1st. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Monday, August 31st.

NewGenIvf Group Stock Performance

Shares of NASDAQ:NIVF opened at $0.47 on Friday. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. The stock has a fifty day moving average of $1.09 and a 200-day moving average of $4.00. NewGenIvf Group has a one year low of $0.45 and a one year high of $513.00.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on NIVF. Wall Street Zen raised NewGenIvf Group to a “hold” rating in a research report on Saturday, July 4th. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Friday, July 24th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.